In healthcare settings, the risk of infection is enduring.
It can’t be removed – only controlled.
By providing solutions that will help to protect the health of our communities, the global infection control market exists to ease the perpetual risk of infectious illness. By extension, the Global Infection Control Market Report examines the current issues surrounding the industry, as well as suggesting what the future could hold.
Here are some of the report’s key findings for 2022…
Key Geographic Regions
When it comes to locations experiencing significant growth in the market, North America emerges at the top – mostly due to its well-established healthcare infrastructure, high adoption of infection control technologies, and the presence of the key market players in the area.
Similarly, the Asia Pacific region is also tipped to see generous market growth due to its growing healthcare industry, increasing disposable income, and expanding healthcare providers' investments in infection control.
What Is Driving Growth of the Infection Control Market?
The Global Infection Control Market was valued at $32.61 billion in 2020, and is estimated to hit $38.61 billion by 2028.
Much of this growth is a result of increasing infection control awareness, spurred at least in part by the COVID-19 pandemic – which saw a huge increase in demand for cleaning and disinfection products.
Although the effects of lockdowns and travel bans across various countries put extra pressure on pharmaceutical production (and, as a result, raw material demand), this is expected to be a temporary strain on the market.
COVID-19’s legacy increased the number of initiatives to ensure high-level infection prevention – and for good reason. According to the World Health Organization (WHO), at least 30 new diseases emerged in the last 20 years, and infectious diseases kill 17 million people every year.
Furthermore, hospital-acquired infections result in more than 99,000 deaths each year.
The world over, local governments are regulating and issuing various guidelines in order to raise awareness about effective preventative measures; which, in turn, increases the demand for infection control innovation.
Other factors, including the rising geriatric population that is more susceptible to infections, along with improvements in the healthcare infrastructure, are anticipated to propel the market further.
Key Infection Control Products
As healthcare settings work harder and harder to control infection, the sterilisation products and services segment is experiencing a boom.
Products such as UV air purifiers to combat airborne infections are becoming increasingly sought-after, while new innovations – such as sanitisers with high-intensity infection prevention capabilities – are significantly contributing to the growth of the market.
What Is Inhibiting Growth of the Infection Control Market?
As previously mentioned, manufacturing interruptions as a result of COVID-19 have caused supply issues in the market; but the demand remains.
Lack of awareness regarding infection control and stringent regulatory requirements are anticipated to impede market growth – but with continued education and prioritisation, the knowledge gap is closing. Access to infection control products is, of course, also impacted by financial restrictions – but where a budget is available, a larger pot is often seen to be ringfenced for crucial infection control supplies, especially when compared to previous periods.
Infection control is critical, and investing in infection control technology is known to provide exceptional, long-term value.
It’s even been named a ‘best buy for public health’ by the World Health Organisation.
If you’re looking to increase protection against infection in a healthcare setting, look no further. DDC Dolphin can provide the products and guidance you need to deliver a life-saving infection control strategy, all while considering the unique requirements of your patients, staff, facilities and budget.